Lupin's Migalastat Capsules Earn US FDA Tentative Approval

An FDA nod to the Abbreviated New Drug Application submitted (ANDA) by multinational pharma player Lupin Limited (Lupin) has come in. T

Laborie Medical Backs Venture iO Urology Investment

Based out of Portsmouth,,New Hampshire, a world-leading diagnostics and therapy medical technology corporation, Laborie Medical Technologies Corporation, has acquired iO Urology.

Aurobindo Pharma Opens Four Plants in Andhra Pradesh

Today, Aurobindo Pharma announced the completion of four modern 6-AAA injectables and granulation manufacturing facilities in the corporate bracket through its fully owned subsidiaries.

Possible Connection Found Between Delirium and Dementia in Recent Study

This is the report from a new retrospective study initiated in partnership with researchers from the AIHI at Macquarie University in Australia and the UQ in Queensland.

WHO Releases Updated Hepatitis B Guidelines

The World Health Organization (WHO) issued the latest advisory papers on the prevention, diagnosis, and treatment of chronic hepatitis B infection (HBV) at the APASL 2024 in Kyoto, Japan, its annual forum for studying liver diseases.

PLI Schemes Garner Rs 1.06 Trillion; Pharma Dominates

The production-linked incentive (PLI) schemes in the 14 sectors in the Philippines gathered over Rs. 1 060 billion in investments, the biggest shares of which came from pharma and solar modules.

Indian Pharma Seizes Russian Market Amid Western Withdrawal

"The Indian Pharmaceutical Business Finds a Chance in Russia during the Belarussian Retreat The German market was already a leader in Russia as a supplier of pharmaceuticals before last year, as stated in the media reports.

Eli Lilly Commences Clinical Trials For its Weight-loss Pill

Eli Lilly, a US pharmaceutical company, has begun phase three clinical trials in India for an oral medication known as orforglipron. The company has begun clinical trials to investigate the safety and efficacy of orforglipron compared to insulin...

Sirio Unveils Tailored Women's Wellness Platform at Vitafoods Europe

Sirio Pharma, the global nutraceutical contract development and manufacturing organization (CDMO) headquartered in Europe, will launch a women’s health platform that includes hormone health, women’s wellness

Endo Launches Combination Ibuprofen-Famotidine Tablets

Endo family of businesses (Par Pharmaceutical, Inc. in particular) have announced a generic launch of Duexis tablets 800 mg/26.6 mg, the version in which the active pharmaceutical ingredient of Duexis is famotidine.

© 2025 India Pharma Outlook. All Rights Reserved.